Farnesyl pyrophosphate (Farnesyl diphosphate), a 15-carbon isoprenoid derived from the mevalonate (MVA) pathway, acts as a metabolic intermediary. It serves as a TRPM2 (TRP Channel) agonist, facilitating the opening of TRPM2 channels for ion influx. Additionally, it plays a critical role in the biosynthesis of cholesterol, ubiquinones, and geranyl-geranyl pyrophosphate (GGPP), as well as in the process of protein farnesylation decoration [1].